Analysis: Thomas H. Kean Jr's sell of JNJ (Johnson & Johnson)
Assessment: Low signal
Routine, periodic sale of Johnson & Johnson that is highly consistent with the member's historical baseline and likely represents standard portfolio diversification.
- Member: Thomas H. Kean Jr
- Party / state: Republican-NJ
- Chamber: House
- Transaction: Sell
- Amount: $1,001 - $15,000
- Ticker: JNJ
- Company: Johnson & Johnson
- Trade date: 2026-06-02
- Disclosure date: 2026-07-15
- Disclosure lag: 43 days
Executive summary
Thomas H. Kean Jr (House; committees: Energy and Commerce, Foreign Affairs) reported a sale of Johnson & Johnson (JNJ) on 2026-06-02 for $1,001-$15,000 (disclosed 2026-07-15). The trade occurred alongside multiple same-day trades across other tickers (a mix of sales and a purchase) and within a broader personal trading history that includes multiple JNJ sales and no JNJ purchases in the provided dataset. In the issuer’s SEC filing window around the trade, JNJ filed two 8-Ks in April 2026 and multiple Form 4s reported insider transactions dated 2026-05-01 and 2026-06-09 to 2026-06-11.
In the provided trading-history dataset (2024-12-19 to 2026-06-30), the member has 6 JNJ transactions, all reported as sales, with the 2026-06-02 sale being one of three smaller-range ($1,001-$15,000) JNJ sales listed (others: 2026-03-26 and 2026-06-29). The analyzed sale was part of a concentrated batch of member activity spanning 2026-06-01 to 2026-06-02 that included multiple small-range sales (MKL, GOOGL, SYK, MSFT, CHKP) and purchases (GIL, EQT). No matched JNJ purchase appears in the provided dataset, so the realized return for these JNJ sales cannot be computed from the supplied records. Issuer-side filings provided for the window show April 2026 8-K filings (Items 2.02/8.01/9.01 and 5.07/9.01) before the trade date, plus Form 4-reported insider transactions dated 2026-05-01 and 2026-06-09 to 2026-06-11 (including one open market/private sale by an EVP on 2026-06-11). Cross-member trading data included in the prompt indicates at least one other member transaction in JNJ on the same date (2026-06-02 purchase by Ro Khanna) and additional purchases within the following two weeks (2026-06-09 and 2026-06-16). Because Congress.gov, Federal Register, Regulations.gov, USAspending, and live news searches were not accessible here, this report cannot confirm or exclude contemporaneous legislative, hearing, regulatory, or contracting catalysts tied to the member’s committees or JNJ’s sector during the relevant windows.
Timeline
- 2026-04-14 — Johnson & Johnson filed Form 8-K (Items reported: 2.02, 8.01, 9.01).
- 2026-04-28 — Johnson & Johnson filed Form 8-K (Items reported: 5.07, 9.01).
- 2026-05-04 — Form 4 filed (accession 0000200406-26-000115) reporting transactions dated 2026-05-01 for EVP John C. Reed (codes M and F).
- 2026-06-01 — Member portfolio activity: CHKP sold twice; EQT purchased twice (each $1,001-$15,000).
- 2026-06-02 — TRADE (analyzed): JNJ sale ($1,001-$15,000) by Thomas H. Kean Jr (self). Same-day additional member trades: MKL sale; GOOGL sale; GIL purchase; SYK sale; MSFT sale (each $1,001-$15,000).
- 2026-06-02 — Cross-member activity (provided dataset): Ro Khanna purchased JNJ ($1,001-$15,000).
- 2026-06-09 — Insider transactions dated 2026-06-09: Directors Woods, Pinto, and Hewson reported grant/award acquisitions (code A) in Form 4 filings dated 2026-06-11.
- 2026-06-11 — Insider transactions dated 2026-06-11: EVP Kathryn E. Wengel reported option/derivative exercises (code M) and an open market or private sale (code S) in Form 4 filing dated 2026-06-12.
- 2026-07-15 — Disclosure filed for the 2026-06-02 JNJ sale by Thomas H. Kean Jr.
Independent analysis of public financial disclosures. Not financial or investment advice.